The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Intensity Therapeutics Inc (NASDAQ: INTS) closed at $0.32 down -0.63% from its previous closing price of $0.32. In other words, the price has decreased by -$0.63 from its previous closing price. On the day, 2.07 million shares were traded.
Ratios:
For a deeper understanding of Intensity Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.30.
Stock Price History:
Over the past 52 weeks, INTS has reached a high of $5.10, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -63.77%, while the 200-Day Moving Average is calculated to be -86.33%.
Shares Statistics:
A total of 15.26M shares are outstanding, with a floating share count of 10.02M. Insiders hold about 45.56% of the company’s shares, while institutions hold 14.07% stake in the company.
Earnings Estimates
The market rating of Intensity Therapeutics Inc (INTS) is currently shaped by the ongoing analysis conducted by 1 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.7 and -$0.7 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.45 and -$0.5.
